Safety and Efficacy of the Universal Neonatal Foot Orthosis in the Treatment of Metatarsus Adductus (MTA)

Metatarsus Adductus Clinical Trial

Official title: Safety and Efficacy of the Universal Neonatal Foot Orthosis in the Treatment of Metatarsus Adductus (MTA)

Status Not yet recruiting

Clinical Trial Summary

This is a prospective, randomized, control, open label study in which up to 50 subjects with metatarsus adductus (MTA) will be enrolled. Subjects will be treated with the standard casting or using the UNFO-s device for total time of 20 weeks.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Metatarsus Adductus
• Metatarsus Varus

• NCT number: NCT01600183
• Study type: Interventional
• Source: Unfo Ltd.
• Contact: Dan Atar, Prof
• Phone: 972-506264277
• Email: dan_atar@yahoo.com
• Status: Not yet recruiting
• Phase: N/A
• Start date: August 2012